Edition:
United Kingdom

Cymabay Therapeutics Inc (CBAY.OQ)

CBAY.OQ on NASDAQ Stock Exchange Global Select Market

5.73USD
3:38pm BST
Change (% chg)

$-0.09 (-1.55%)
Prev Close
$5.82
Open
$5.94
Day's High
$5.97
Day's Low
$5.65
Volume
17,104
Avg. Vol
311,168
52-wk High
$14.00
52-wk Low
$4.82

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.373
FY 2018 Dec '18 0.00 -0.327
Sep '18 0.00 -0.314
Jun '18 0.00 -0.298
Mar '18 0.00 -0.316
FY 2017 Dec '17 5.21 -0.114
Sep '17 0.00 -0.206
Jun '17 0.00 -0.311
Mar '17 4.79 -0.201
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 9 0.00 0.00 0.00 0.00
Quarter Ending Dec-19 9 0.00 0.00 0.00 0.00
Year Ending Dec-19 9 0.00 0.00 0.00 7.00
Year Ending Dec-20 9 5.56 50.00 0.00 49.75
Earnings (per share)
Quarter Ending Sep-19 10 -0.37 -0.32 -0.45 -0.35
Quarter Ending Dec-19 10 -0.38 -0.31 -0.50 -0.36
Year Ending Dec-19 10 -1.49 -1.36 -1.74 -1.20
Year Ending Dec-20 10 -1.57 -0.91 -2.03 -0.72
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 98.31 33.85
P/E High - Last 5 Yrs. -- 169.52 54.29
P/E Low - Last 5 Yrs. -- 53.54 28.22
Beta 1.15 1.29 0.99
Price to Sales (TTM) -- 42.65 7.90
Price to Book (MRQ) 1.64 12.25 4.38
Price to Tangible Book (MRQ) 1.64 17.14 5.07
Price to Cash Flow (TTM) -- 64.56 23.70
% Owned Institutions -- 3.24 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.11 1.67
Dividend Yield - 5 Year Avg -- 0.05 1.37
Dividend 5 Year Growth Rate -- 0.86 6.82
Payout Ratio(TTM) -- 2.55 46.67

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 53.93 14.65
Sales (TTM) vs TTM 1 Yr. Ago -100.00 51.52 8.45
Sales - 5 Yr. Growth Rate -- 33.42 9.43
EPS (MRQ) vs Qtr. 1 Yr. Ago -17.85 -8.31 19.40
EPS (TTM) vs TTM 1 Yr. Ago -38.53 -- --
EPS - 5 Yr. Growth Rate -- 22.74 7.15
Capital Spending - 5 Yr. Growth Rate -- 26.66 8.01

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.76 2.52
Current Ratio (MRQ) 18.66 3.87 3.52
LT Debt to Equity (MRQ) 0.00 7.63 12.61
Total Debt to Equity (MRQ) 0.00 20.26 17.64
Interest Coverage (TTM) -- 30.21 14.93

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 21.69 50.25
Gross Margin - 5 Yr. Avg. -- 58.96 51.36
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -1,691.12 -12.49 16.42
Operating Margin (TTM) -- -124.67 -6.97
Operating Margin - 5 Yr. Avg. -1,697.28 -28.74 11.87
Pre-Tax Margin (TTM) -- -126.48 -7.30
Pre-Tax Margin - 5 Yr. Avg. -1,742.22 -34.06 15.72
Net Profit Margin (TTM) -- -132.21 -11.11
Net Profit Margin - 5 Yr. Avg. -1,742.22 -38.92 11.11
Effective Tax Rate (TTM) -- 17.21 20.61
Effective Tax Rate - 5 Yr. Avg. -- 18.84 24.51

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 10,400,894 870,638,159
Net Income/Employee (TTM) -1,828,326 2,349,448 101,855,832
Receivable Turnover (TTM) -- 12.32 5.88
Inventory Turnover (TTM) -- 2.26 3.66
Asset Turnover (TTM) 0.00 0.32 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -31.05 6.26 10.25
Return on Assets - 5 Yr. Avg. -55.52 6.14 11.17
Return on Investment (TTM) -33.17 7.52 12.69
Return on Investment - 5 Yr. Avg. -69.80 7.98 14.15
Return on Equity (TTM) -33.47 7.94 17.13
Return on Equity - 5 Yr. Avg. -77.31 8.90 15.53
  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % -58.96 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cymabay Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -10.89 -13.37 88 4
13 Week -51.00 -52.39 35 7
26 Week -27.33 -36.01 90 20
52 Week -43.34 -46.87 99 12
YTD -18.93 -32.84 94 9
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 194
Total Shares Held: 71,693,766
3 Mo. Net Change: 3,728,634
# New Positions: 7
# Closed Positions: 2
# Increased Positions: 15
# Reduced Positions: 9
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.